Latest diabetic peripheral neuropathy Stories
RnRMarketResearch.com adds “Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014” to its store.
A company known for its natural approach to treating various ailments, Neuracel has launched its latest product, called the Ultimate Neuropathy Support System at http://www.neuracel.com.
LA JOLLA, Calif., June 16, 2011 /PRNewswire/ -- Cebix Incorporated announced today it is advancing the development of modified C-peptide for the treatment of complications of diabetes.
HealthCore study shows Metanx also reduces health plan costs.
More than 20 million Americans are living with diabetes, and that number is expected to increase by more than 5 million by 2010.
DOYLESTOWN, Pa., Nov. 12 /PRNewswire-FirstCall/ -- Quigley Pharma Inc., a wholly-owned subsidiary of The Quigley Corporation announced today that the last subject in the Phase IIb Study is scheduled to complete treatment on November 25, 2008.
Adolor Corporation (Nasdaq: ADLR) announced today the initiation of a third Phase 2a study of ADL5859, a novel Delta opioid agonist in development for the treatment of pain.
- In medieval musical notation, a sign or neume denoting a shake or trill.